26B-4-212. Institutional review board -- Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product.
(1) As used in this section: "Approved study" means a medical research study: the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and that is approved by an IRB. "Cannabinoid product" means the same as that term is defined in Section. 58-37-403 "Cannabis" means the same as that term is defined in Section. 58-37-403 "Expanded cannabinoid product" means the same as that term is defined in Section. 58-37-403 "Institutional review board" or "IRB" means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.
(2) A person conducting an approved study may, for the purposes of the study: process a cannabinoid product or an expanded cannabinoid product; possess a cannabinoid product or an expanded cannabinoid product; and administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study.
(3) A person conducting an approved study may: import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if: the importation complies with federal law; and the person uses the cannabis, cannabinoid product, or expanded cannabinoid product in accordance with the approved study; or obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse.
(4) A person conducting an approved study may distribute cannabis, a cannabinoid product, or an expanded cannabinoid product outside the state if: the distribution complies with federal law; and the distribution is for the purposes of, and in accordance with, the approved study.